Synagis - palivizumab
Navigation: NDC > Supplier starting with: M > MEDIMMUNE, LLC| Field | Value |
|---|---|
| NDC Code: | 60574-4113 |
| Proprietary Name: | Synagis |
| Suffix: | |
| Non-Proprietary Name: | palivizumab |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAMUSCULAR |
| Original Marketing Date: | 19-06-1998 |
| Category Name: | BLA |
| Application Number: | BLA103770 |
| Labeler: | MEDIMMUNE, LLC |
| Substance Name: | PALIVIZUMAB |
| Active Numerator Strength: | 100 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Antibodies, Monoclonal [Chemical/Ingredient],Fusion Protein Inhibitors [MoA],Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
| DEA Schedule: |